CPhI India 2026 will take place on 23-25 November 2026 in Delhi (IICC, Yashobhoomi & associated venues). The event gathers suppliers, manufacturers, and decision-makers across the full pharmaceutical value chain, making it a cornerstone for pharma business in South Asia and beyond.

Focus & Topics

At CPhI India 2026, participants will explore active pharmaceutical ingredients (APIs), excipients, finished dosage forms and natural extracts. The exhibition also features fine chemicals and intermediates, lab chemicals, and biopharma & biosimilar offerings. Alongside chemical products, the event highlights machinery, cleanroom tech, packaging, analytical labs, and state-of-the-art production equipment via its PMEC segment.

Moreover, the fair addresses current industry trends: sustainability in pharma manufacturing, outsourcing & contract services, biotech solutions, and regulatory developments.

Visitors & Attendance

CPhI India attracts a large and international audience — the 2025 edition welcomed more than 50,000 professionals from over 120 countries, with 2,000+ exhibiting companies across 120,000 m². The attendee mix includes procurement managers, quality assurance staff, R&D specialists, regulatory experts, contract-service providers, and senior executives from pharma and biotech companies.

This diversity ensures that exhibitors meet both local Indian firms and global buyers — offering substantial networking and business potential.

Outstanding Opportunities

CPhI India 2026 offers unrivalled access to India’s vast and growing pharmaceutical market. Given India’s role as a global manufacturing hub for generics and vaccines, the fair serves as a gateway to international supply chains and export partnerships.

Exhibitors can showcase APIs, excipients, finished products, and technology solutions to a broad, high-level audience that actively seeks sourcing, outsourcing, and contract manufacturing partners. The combination of chemical suppliers, machinery providers, lab-services, and contract-manufacturers all under one roof streamlines procurement, forming a complete supply-chain marketplace.

Additionally, the fair’s “Start-Up Market” and innovation zones provide a platform for emerging companies to pitch new technologies or formulations, connect with investors, and find collaborators. For established firms, the event offers a chance to stay ahead in regulatory trends, manufacturing standards, and market demands.

Lastly, with strong global participation, CPhI India offers opportunities for cross-border partnerships, export deals, and global product launches — significantly strengthening a company’s international footprint.

Key Industries Represented

• Pharmaceutical manufacturing (APIs, finished dosage, generics)
• Biopharmaceuticals and biosimilars
• Chemical intermediates and fine chemicals
• Excipients and raw-material suppliers
• Lab and analytical services
• Machinery, cleanroom, and production equipment providers
• Packaging, clean-technology, and regulatory-compliance services
• Contract development and manufacturing organizations (CDMOs / CMOs)

CPhI India 2026 stands out as a central hub for pharma sourcing, innovation, and global networking. Its scale, scope, and diverse attendees make it a must-attend for anyone involved in pharmaceutical production, supply chain, and global distribution.